No. of patients | Percentage (%) | |
---|---|---|
Age at implant (years) | ||
Median (range) | 15 (4–20) | |
Gender | ||
Male | 7 | 70 |
Female | 3 | 30 |
Pathology of primary tumor | ||
Fibrosarcoma | 5 | 50 |
Alveolar soft tissue sarcoma | 2 | 20 |
Primitive neuroectodermal tumor | 1 | 10 |
Epithelioid sarcoma | 1 | 10 |
Rhabdomyosarcoma | 1 | 10 |
Primary tumor stage (AJCC 7th de, 2010) | ||
I A | 3 | 30 |
II A | 1 | 10 |
III | 3 | 30 |
IV | 3 | 30 |
Pre-seed implant therapy | ||
Surgery + EBRT + CTx | 1 | 10 |
Surgery + EBRT | 3 | 30 |
Surgery + CTx | 1 | 10 |
EBRT + CTx | 2 | 20 |
Surgery | 3 | 30 |
Follow-up (month) | ||
Median (range) | 27.5 (6–107) |